GABA-transaminase and glutamic acid decarboxylase changes in the brain of rats treated with pyrithiamine.
Pyrithiamine, a thiamine phosphokinase inhibitor, was fed to rats on a thiamine-deficient diet, producing weight loss, ataxia and loss of righting reflex in 10 days. Some rats were then sacrificed; others were returned to a normal diet, to be sacrificed only when their weight had returned to pre-experimental levels. Rats were sacrificed for assay of glutamic acid decarboxylase (GAD) and choline acetyltransferase (ChAT) activities in homogenates of eight brain regions or were perfused for gamma-aminobutyric acid transaminase (GABA-T) histochemistry. GAD activity was significantly reduced in symptomatic rats in the thalamus greater than cerebellum greater than midbrain greater than pons/medulla. GABA-T staining was similarly reduced, with greatest losses in the thalamus greater than inferior colliculus greater than pons greater than medulla. ChAT activity was not significantly altered in any brain area. Following return to a normal diet. GAD activity was significantly recovered in all areas except the thalamus. GABA-T staining recovered, at least partially, in all areas affected.
D000612:4-Aminobutyrate Transaminase / Q000378:metabolism*; D000818:Animals; D001921:Brain / Q000201:enzymology*; D001923:Brain Chemistry / Q000187:drug effects; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D005968:Glutamate Decarboxylase / Q000378:metabolism*; D006651:Histocytochemistry; D008297:Male; D011726:Pyridinium Compounds / Q000008:administration & dosage*; D011745:Pyrithiamine / Q000008:administration & dosage*; D051381:Rats; D011919:Rats, Inbred Strains; D013832:Thiamine Deficiency / Q000201:enzymology
D011726:Pyridinium Compounds; D011745:Pyrithiamine; D002795:Choline O-Acetyltransferase; D000612:4-Aminobutyrate Transaminase; D005968:Glutamate Decarboxylase